Status:
UNKNOWN
MEDCEM PC and MTA in Pulpotomies of Primary Molars
Lead Sponsor:
Universitat Internacional de Catalunya
Conditions:
Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.
Eligibility:
All Genders
3-10 years
Phase:
PHASE4
Brief Summary
The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MEDCEM PC and MTA when used as pulp dressings following pulpotomy in human primary molars.
Eligibility Criteria
Inclusion
- healthy children
- molars showing: symptomless exposure of vital pulp by caries no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) the possibility of proper restoration of the teeth no physiological resorption of more than one-third of the root
Exclusion
- presence of systemic pathology
- history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02291120
Start Date
March 1 2014
End Date
December 1 2016
Last Update
November 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitat Internacional de Catalunya
Sant Cugat del Vallès, Barcelona, Spain, 08195